Infections, Pandemics, and Sleep Disorders

被引：0
作者：
Kolokolov O.V. [1 ]
Salina E.A. [1 ]
Yudina V.V. [1 ]
Shuldyakov A.A. [1 ]
Runnova A.E. [1 ]
机构：
[1] Razumovsky Saratov State Medical University, Russian Ministry of Health, Saratov
来源：
Neuroscience and Behavioral Physiology | 2022年 / 52卷 / 3期
关键词：
anxiety; COVID-19; depression; infection; melatonin; pandemics; SARS-CoV-2; sleep impairments; sleeplessness; Sonnovan;
D O I：
10.1007/s11055-022-01242-2
中图分类号：
学科分类号：
摘要：
Studies of the neurological symptoms and signs associated with the acute and late phases of infectious diseases are important in pandemic conditions. The novel coronavirus infection (COVID-19) pandemic has increased the number of patients with sleeplessness, this being an adverse prognostic factor for infections. This review addresses the factors and mechanisms of sleep impairments and their relationship with inflammation and immune system dysfunction in infectious diseases. In particular, impairments to the functioning of the melatoninergic system are discussed as the cause of sleeplessness during pandemics. The relevance of developing measures for rehabilitating patients, particularly use of Sonnovan to restore normal sleep, which plays a fundamental role in supporting people’s mental and physical health, is emphasized. © 2022, Springer Nature Switzerland AG.
引用
收藏
页码：319 / 325
页数：6
相关论文
共 53 条
[1]  
National Library of Medicine
[2]  
Poluektov M.G., Sleep and neuroplasticity, Zh. Nevrol. Psikhiatr., Spec. Iss., 119, 4-2, pp. 7-7, (2019)
[3]  
Koval'zon V.M., The nature of sleep, Priroda, 8, pp. 172-179, (1999)
[4]  
Limousin N., Dehais C., Gout O., Et al., A brainstem inflammatory lesion causing REM sleep behavior disorder and sleepwalking (parasomnia overlap disorder), Sleep Med., 10, 9, pp. 1059-1062, (2009)
[5]  
Clark I.A., Vissel B., Infl ammation-sleep interface in brain disease: TNF, insulin, orexin, J. Neuroinflammation, 11, (2014)
[6]  
Coogan A.N., Wyse C.A., Neuroimmunology of the circadian clock, Brain Res., 1232, pp. 104-112, (2008)
[7]  
Beynon A.L., Coogan A.N., Diurnal, age, and immune regulation of interleukin-1β and interleukin-1 type 1 receptor in the mouse suprachiasmatic nucleus, Chronobiol. Int., 27, pp. 1546-1563, (2010)
[8]  
Sadki A., Bentivoglio M., Kristensson K., Nygard M., Suppressors, receptors and effects of cytokines on the aging mouse biological clock, Neurobiol. Aging, 28, 2, pp. 296-305, (2007)
[9]  
Lundkvist G.B., Robertson B., Mhlanga J.D., Et al., Expression of an oscillating interferon-gamma receptor in the suprachiasmatic nuclei, Neuroreport, 9, 6, pp. 1059-1063, (1998)
[10]  
Banisadr G., Fontanges P., Haour F., Et al., Neuroanatomical distribution of CXCR4 in adult rat brain and its localization in cholinergic and dopaminergic neurons, Eur. J. Neurosci., 16, 9, pp. 1661-1671, (2002)
123456